Reframing outcome measures for thrombolytics in acute ischemic stroke

Authors

Brandon Baker, DMC-Sinai Grace Hospital Emergency Medicine ResidencyFollow
Charles W. Kropf, University of Michigan Emergency Medicine ResidencyFollow
Nicholus Yee, Oakwood Annapolis Hospital Family Medicine ResidencyFollow
James Peter Meza, Wayne State University School of MedicineFollow

Abstract

An informed consent conversation examining relevant research and discussing the potential benefits and harms of thrombolytic therapy in acute stroke.

DOI

10.22237/crp/1498867440

Recommended Citation

Baker BJ, Kropf CW, Yee NH, Meza JP. Reframing outcome measures for thrombolytics in acute ischemic stroke. Clin. Res. Prac. 2017;3(2):eP1518. doi: 10.22237/crp/1498867440